POSTERS possible when no muscle relaxant is injected. Remifentanil use with an objective of effect site concentration appears to be a solution for anesthesia for this type of surgery. Our work consists in studying the optimal concentration needed to realize the surgery without the necessity to use muscle relaxant and with the lowest side effects.
Method: Observation of practice in the department of Ear, Nose and Throat (ENT) surgery at Brest University Hospital. Fifty-two patients undergoing thyroid surgery were assigned in 4 groups according to site effect remifentanil concentration: 4, 6, 7, and 8 ng/mL. Intubation was done by a tracheal tube with EMG electrodes to monitor recurrent laryngeal nerve during surgery. Noninvasive arterial blood pressure, heart rate changes, and BIS values were recorded every minute. Intubation conditions were assessed as excellent, good, or bad.
Results: Intubation conditions were better when remifentanil site effect concentration increased (P = .001). With a 4 ng/mL concentration, intubation conditions were always bad. On the other side, an 8 ng/mL concentration always gave good intubation conditions. Furthermore, with 4 ng/mL concentration of remifentanil, heart rate was significantly increased. There was no significant difference for all other data.
Conclusion: In our study, tracheal intubation for thyroid surgery using recurrent laryngeal nerve monitoring can be performed without a neuromuscular blocking agent with good conditions when remifentanil site effect concentration is above 8 ng/mL. At this concentration, no hemodynamic adverse effect was observed.
Head and Neck Surgery Skin Metastases from Noncutaneous Head and Neck Cancers
Henry John Emanuel, MBChB, BDS (presenter); Patrick Emanuel; Andrew J. Kleinberger, MD; Eric M. Genden, MD Objective: Investigate the distribution of spread, histopathologic characteristics, and prognostic implications of skin metastases arising from primary cancers of the head and neck. We present a case series of patients with skin metastases from non-cutaneous malignancies of the head and neck and perform a complete literature review on this topic.
Method: Patients with skin metastases arising from noncutaneous cancers of the head and neck were identified by a dermatopathologist and cases were reviewed. A comprehensive literature search was performed and appropriate articles were selected and analyzed for relevant cases.
Results: Twelve patients with skin metastases from noncutaneous carcinomas of the head and neck were identified. The most common primary site, histology, and location of spread was the parotid gland (33%), squamous cell carcinoma (42%), and scalp (25%), respectively. A literature search yielded 97 cases of dermal metastases from head and neck malignancies since 1972. Oral cavity was the most frequent site of origin, but many cases involved direct tumor extension rather than true metastatic spread. Skin metastases typically presented as a discrete nodule within the scalp, but morphology and distribution varied. Overall prognosis is poor with long-term survivors occasionally reported.
Conclusion: Skin metastases are clinically rare, occurring in less than 1% of head and neck cancers, and when present typically herald a poor overall prognosis. Information regarding their distribution and clinical presentation is of particular importance to the otolaryngologist and oncologist in identifying, counseling, and treating patients diagnosed with skin metastases. Method: A retrospective review was performed by examining the records and reviewing the pathology of 48 patients with buccal squamous cell carcinoma treated at UCLA Medical Center from 1970 to 2009. Forty-eight patients were identified that received first-time surgical therapy for squamous cell carcinoma of the buccal mucosa and had adequate follow-up.
Head and Neck Surgery Squamous Cell Carcinoma of the Buccal Mucosa: A 40-Year Review
Results: Treatment entailed surgery alone in 18 out of 48 patients (37.5%) and surgery followed by radiation therapy in 30 out of 48 patients (62.5%). Composite resection of the tumor was performed in 17 out of 48 patients (35.4%) and ipsilateral neck dissections were performed in 37 out of 48 patients (77.1%). Oneyear observed actuarial disease-free survival rates were 60%, 46%, 0%, and 40% for T1 through T4, respectively. Univariate analysis revealed increased age as a risk factor (P = .062), and multivariate analysis demonstrated age as a risk factor and performance of neck dissection having a decreased risk of recurrence (P = .029 and .023, respectively).
Conclusion:
We report fairly high disease-free survival rates in this patient population. Performance of neck dissection and younger age were associated with a favorable prognosis. Performance of neck dissection may decrease the risk of recurrences in primary squamous cell carcinoma of the buccal mucosa.
Head and Neck Surgery Submucosal Dissection for Superficial Pharyngeal Cancer
Ichiro Tateya, MD, PhD (presenter); Man Ki Muto; Morimasa Kitamura; Shinpei Kada; Shuko Morita; Juichi Ito, MD, PhD; Shigeru Hirano, MD, PhD Objective: We have previously reported that narrow band imaging (NBI) combined with magnifying endoscopy is useful in
